Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

site optimization

- PMLiVE

UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Invests in Genomics England alliance, plus clinical trials expansion

- PMLiVE

Retaining reader value in plain language summaries of clinical studies

Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries

- PMLiVE

Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit

Proposals come as EU plans major upgrade in trials regulation

- PMLiVE

Can a post-Brexit UK stay aligned with Europe on clinical research?

There's still no guarantee the UK can keep in step with EU

- PMLiVE

Pfizer drug gets speedy FDA review for rare heart failure complication

Tafamidis chalked up a comprehensive win in its phase III trials programme

- PMLiVE

NHS England pledges to streamline clinical trial setup

The process will also target the procedure for reimbursements in additional treatment costs

- PMLiVE

IMI calls for advancements in machine learning and digital clinical trials

Will reserve up to €82m for universities, SMEs and patient organisations

- PMLiVE

Novartis pushes ‘virtual’ clinical trial concept

Teams up with Science 37 to run ten digital-based trials over the next three years

translational pharmacology medicine dose

UK government updates the Model Clinical Trials Agreement

New regulation aims to speed-up R&D

- PMLiVE

AllTrials tracker site names clinical trial non-reporters

The FDAAA site seeks to highlight the failings of the FDA Amendments Act 2007

Finding the patient voice

How patients feel and speak about clinical trials

The gold standard of scientific evidence

Will randomised controlled trials become a thing of the past?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links